| Literature DB >> 26748260 |
Andres Rubiano1, Yanfei Qi2, Dominic Guzzo2, Anandharajan Rathinasabapathy3, Kyle Rowe1, Carl Pepine2, Chelsey Simmons4.
Abstract
Extensive remodeling of the myocardium is seen in a variety of cardiovascular diseases, including systemic hypertension. Stem cell therapy has been proposed to improve the clinical outcomes of hypertension, and we hypothesized that changes in mechanical properties of the myocardium would accompany the progression of disease and the results of treatment conditions. Using spontaneously hypertensive rats (SHR) as a model of hypertension, we treated 13-week-old hypertensive rats with a single injection of adipose-derived stem cells (ADSC) isolated from a normotensive control. We indented the isolated ventricles of control, untreated sham-injected SHR, and ADSC-treated SHR hearts with a custom cantilever-based system and fit the resulting data to a standard linear solid model. SHR animals had higher blood pressure (198.4±25.9mmHg) and lower ejection fraction (69.9±4.2%) than age-matched control animals (109.0±1.6mmHg, 88.2±1.3%), and increased viscoelastic properties accompanied these clinical changes (right ventricle effective stiffness, SHR: 21.97±5.10kPa, Control: 13.14±3.48kPa). ADSC-treated animals saw improvement in clinical parameters compared to the untreated SHR group, which was also accompanied by a significant restoration of viscoelastic properties of the myocardium (ACSD-treated SHR: 9.77±6.96kPa).Entities:
Keywords: Cardiac material properties; Cell therapy; Spontaneously hypertensive rat; Tissue mechanics
Mesh：
Year: 2015 PMID： 26748260 PMCID： PMC4860127 DOI： 10.1016/j.jmbbm.2015.11.041
Source DB: PubMed Journal: J Mech Behav Biomed Mater ISSN： 1878-0180